Aarti Drugs had announced a temporary shutdown of a specific product line following a bromine gas leak incident at its manufacturing facility. The leak occurred during the transfer of bromine from a tanker to a storage tank.
As a precautionary measure, the Maharashtra Pollution Control Board (MPCB) ordered the company to cease production of the affected product upon completion of the existing batch. The shutdown commenced on July 18, 2024.
Today, August 7, 2024, Aarti Drugs received conditional approval from the MPCB to resume production. However, the company must obtain additional clearance from the Directorate of Industrial Safety and Health (DISH) before restarting operations.
| Subscribe To Our Free Newsletter |
